WallStreetZenWallStreetZen

NASDAQ: RNLX
Renalytix PLC Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their RNLX stock forecasts and price targets.

Forecast return on equity

Is RNLX forecast to generate an efficient return?

Forecast return on assets

Is RNLX forecast to generate an efficient return on assets?
Company
N/A
Industry
6.29%

RNLX revenue forecast

What is RNLX's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.5M+86.72%
Avg 2 year Forecast
$15.0M+522.41%
RNLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RNLX revenue growth forecast

How is RNLX forecast to perform vs Health Information Services companies and vs the US market?
Company
86.72%
Industry
13.35%
Market
13.2%
RNLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RNLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RNLX vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
RNLX$0.80N/AN/A
EUDA$1.75N/AN/A
NUTX$0.70$15.00+2,049.00%Strong Buy
BEAT$1.93$8.00+314.51%Buy
HLTH$0.15$0.50+244.83%Hold

Renalytix Stock Forecast FAQ

What is RNLX's revenue growth forecast for 2024-2025?

(NASDAQ: RNLX) Renalytix's forecast annual revenue growth rate of 86.72% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.35%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.2%.

Renalytix's revenue in 2024 is $2,410,000.On average, 1 Wall Street analysts forecast RNLX's revenue for 2024 to be $449,685,702, with the lowest RNLX revenue forecast at $449,685,702, and the highest RNLX revenue forecast at $449,685,702.

In 2025, RNLX is forecast to generate $1,498,952,340 in revenue, with the lowest revenue forecast at $1,498,952,340 and the highest revenue forecast at $1,498,952,340.

If you're new to stock investing, here's how to buy Renalytix stock.

What is RNLX's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: RNLX) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 6.29%.

What is RNLX's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: RNLX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.